EMBIO Diagnostics, a leading innovator in the deep tech sector, proudly represented Cyprus at GITEX Global 2024, one of the world’s most prestigious technology and startup expos. Six pioneering companies highlighted Cyprus's innovative potential as part of the Cypriot delegation, with EMBIO Diagnostics making a remarkable impact through its advanced technology solutions.

During the event, EMBIO Diagnostics showcased the strength of its cutting-edge deep tech technologies, B.EL.D™, and airbeld™, emphasizing their global applications. The company’s participation provided a unique opportunity to explore the UAE market, offer insights into industry trends, and foster key strategic partnerships. Their presentations captured the attention of international audiences and industry experts. 

Constantinos Loizou, CEO of EMBIO Diagnostics, commented on the success: “Our experience at GITEX Global 2024 was transformative, both for our team and the future of our business. We are excited to have shared our innovations with a global audience, deepening our expertise in the UAE market while showcasing Cyprus’ potential in the deep tech sector.”

As the global technology landscape continues to evolve, EMBIO Diagnostics remains at the forefront, developing solutions that enhance quality of life through advanced real-time detection technologies. This successful showcase at GITEX Global 2024 marks the start of the company’s journey into international markets, aligning with its broader global expansion strategy.

For more information about EMBIO Diagnostics and their innovations, please visit www.embiodiagnostics.eu. 

EMBIO Diagnostics is a fast-growing deep tech company specializing in developing innovative, digital, portable sensor-based devices for rapid diagnostics. These advanced devices serve a wide range of sectors, including food safety, environmental monitoring, and healthcare. With a strong focus on global innovation, EMBIO Diagnostics integrates machine learning and AI into its portable diagnostic solutions, enabling real-time data collection, analysis, and reporting. With a commitment to excellence and a track record of industry recognition, EMBIO Diagnostics remains at the forefront of technological advancement, poised to meet the evolving needs of diverse industries worldwide. 

For more information, visit  www.embiodiagnostics.eu , www.airbeld.com